Stock Events

Stock Events

10x Genomics 

$22.33
167
+$0.28+1.27% Thursday 20:00

Statistics

Day High
22.91
Day Low
21.11
52W High
23.56
52W Low
6.78
Volume
1,277,105
Avg. Volume
2,617,968
Mkt Cap
2.63B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.47
-0.22
0.03
0.28
Expected EPS
-0.269384
Actual EPS
N/A

Financials

-6.77%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.29BRevenue
-87.09MNet Income

Analyst Ratings

$19.80Average Price Target
The highest estimate is 25.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
36%
Hold
64%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TXG. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with technologies that overlap with 10x Genomics' offerings.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers long-read sequencing technologies that compete with 10x Genomics' products for genomic and transcriptomic analysis.
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics provides optical genome mapping solutions, which compete with 10x Genomics' chromosomal conformation capture technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is involved in CRISPR gene editing, a field that requires detailed genomic analysis, where 10x Genomics' products are used.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is another key player in the gene editing space, relying on genomic insights where 10x Genomics' technologies can be applied.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine operates in the genome editing sector, competing for the same genomic analysis market as 10x Genomics.
Teladoc Health
TDOC
Mkt Cap1.53B
Teladoc Health, while primarily a telehealth company, is expanding into primary care and chronic condition monitoring, indirectly competing with 10x Genomics in the data analysis and personalized medicine space.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with 10x Genomics in the genomic analysis market for oncology.
Twist Bioscience
TWST
Mkt Cap1.99B
Twist Bioscience operates in the synthetic biology space, producing synthetic DNA that is used in many of the same applications as 10x Genomics' products.

About

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Show more...
CEO
Dr. Serge Saxonov Ph.D.
Employees
1306
Country
US
ISIN
US88025U1097

Listings

LSE
GB
0A88.LSE
XNAS
US
TXG
MX
MX
TXG.MX
BOATS
BOATS
TXG.BOATS

0 Comments

Share your thoughts

FAQ

What is 10x Genomics stock price today?▼
The current price of TXG is $22.33 USD — it has increased by +1.27% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange 10x Genomics stocks are traded under the ticker TXG.
Is 10x Genomics stock price growing?▼
TXG stock has risen by +14.63% compared to the previous week, the month change is a -1.28% fall, over the last year 10x Genomics has showed a +180.18% increase.
What is 10x Genomics market cap?▼
Today 10x Genomics has the market capitalization of 2.63B
When is the next 10x Genomics earnings date?▼
10x Genomics is going to release the next earnings report on May 06, 2026.
What were 10x Genomics earnings last quarter?▼
TXG earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.2 USD resulting in a +35.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 10x Genomics revenue for the last year?▼
10x Genomics revenue for the last year amounts to 1.29B USD.
What is 10x Genomics net income for the last year?▼
TXG net income for the last year is -87.09M USD.
How many employees does 10x Genomics have?▼
As of April 03, 2026, the company has 1,306 employees.
In which sector is 10x Genomics located?▼
10x Genomics operates in the Health Care sector.
When did 10x Genomics complete a stock split?▼
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?▼
10x Genomics is headquartered in Pleasanton, US.